These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8176369)

  • 1. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice.
    Cafruny WA; Bradley SE; Rowland RR
    Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: relationship to IgG2a- and IgG2b-specific polyclonal activation of B cells.
    Hu B; Even C; Plagemann PG
    Viral Immunol; 1992; 5(1):27-38. PubMed ID: 1610489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.
    Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG
    J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lymphocytes.
    Li X; Hu B; Harty J; Even C; Plagemann PG
    Viral Immunol; 1990; 3(4):273-88. PubMed ID: 2076177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.
    Cafruny WA; Jones QA; Haven TR; Zitterkopf NL; Plagemann PG; Rowland RR
    Virus Res; 2003 Mar; 92(1):83-7. PubMed ID: 12606079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
    Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
    Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of SCID mice with lactate dehydrogenase-elevating virus stimulates B-cell activation.
    Bradley DS; Broen JJ; Cafruny WA
    Viral Immunol; 1991; 4(1):59-70. PubMed ID: 1905935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
    Monteyne P; Coutelier JP
    J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trojan Horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection.
    Cafruny WA; Bradley SE
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3005-12. PubMed ID: 9000091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
    Weiland E; Weiland F; Grossmann A
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
    Rowland RR; Butz EA; Plagemann PG
    J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers, concomitant with polyclonal activation of B cells.
    Anderson GW; Rowland RR; Palmer GA; Even C; Plagemann PG
    J Virol; 1995 Aug; 69(8):5177-85. PubMed ID: 7609091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus but disappear during the chronic phase of infection.
    Even C; Rowland RR; Plagemann PG
    J Virol; 1995 Sep; 69(9):5666-76. PubMed ID: 7637013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice.
    Cafruny WA; Plagemann PG
    Infect Immun; 1982 Sep; 37(3):1001-6. PubMed ID: 7129626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobic IgG-containing immune complexes in the plasma of autoimmune MRL/lpr mice, lactate dehydrogenase-elevating virus-infected mice, and pigs: association with transforming growth factor-beta and pH-dependent amplification.
    Zitterkopf NL; Jones QA; Bradley DS; Durick K; Rowland RR; Plagemann PG; Cafruny WA
    Viral Immunol; 2003; 16(4):511-23. PubMed ID: 14733738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.
    Anderson GW; Even C; Rowland RR; Palmer GA; Harty JT; Plagemann PG
    J Neurovirol; 1995 Sep; 1(3-4):244-52. PubMed ID: 9222362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.
    Cafruny WA; Chan SP; Harty JT; Yousefi S; Kowalchyk K; McDonald D; Foreman B; Budweg G; Plagemann PG
    Virus Res; 1986 Sep; 5(4):357-75. PubMed ID: 3022497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.
    Chen Z; Li K; Rowland RR; Plagemann PG
    J Neurovirol; 1999 Apr; 5(2):200-8. PubMed ID: 10321985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.